The group of Professor Tao Liu reported Cas12a efficient gene editing system in Molecular Cell.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 853
- Publication type:
- Article
Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 10
Results: 12
1
2
The group of Professor Qiang Zhang and Bing He has made important progress in nanodrug transport mechanism.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 857
- Publication type:
- Article
3
The group of Professor Xinjing Tang has made progress in the study of cyclic antisense oligonucleotides as microRNA inhibitors.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 855
- Publication type:
- Article
4
The group of Professor Wanliang Lu has made progress in targeted gene editing systems against metastatic breast cancer.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 851
- Publication type:
- Article
5
Analysis of reimbursement policy for outpatient chronic diseases in basic medical insurance for urban residents in China provincial capitals.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 845, doi. 10.5246/jcps.2021.10.073
- By:
- Publication type:
- Article
6
Preparation and antibacterial activities of metal complexes of norfloxacin.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 838, doi. 10.5246/jcps.2021.10.072
- By:
- Publication type:
- Article
7
Facile extraction of high-purity mangiferin from mango industrial wastes.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 831, doi. 10.5246/jcps.2021.10.071
- By:
- Publication type:
- Article
8
Quantification of flupirtine and its active metabolite D-13223 in human plasma by LC-MS/MS: application to a clinical trial of flupirtine maleate capsules in healthy male Chinese volunteers.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 813, doi. 10.5246/jcps.2021.10.070
- By:
- Publication type:
- Article
9
Discussion on the mechanism of Salvia miltiorrhiza in treating pathological scars based on network pharmacology.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 813, doi. 10.5246/jcps.2021.10.069
- By:
- Publication type:
- Article
10
Virtual screening and high-throughput testing of L1 metallo-β-lactamase inhibitor.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 806, doi. 10.5246/jcps.2021.10.068
- By:
- Publication type:
- Article
11
A stochastic population pharmacodynamic model of QAP14 in the treatment of lung metastases of 4T1 breast cancer.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 794, doi. 10.5246/jcps.2021.10.067
- By:
- Publication type:
- Article
12
High-throughput screening technologies for ion channel drug discovery.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 10, p. 785, doi. 10.5246/jcps.2021.10.066
- By:
- Publication type:
- Article